Total Payments
$7,539
2024 Payments
$1,012
Companies
34
Transactions
195
Medicare Patients
1,813
Medicare Billing
$288,294
Payment Breakdown by Category
Food & Beverage$7,450 (98.8%)
Gifts$59.40 (0.8%)
Education$30.04 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,450 | 191 | 98.8% |
| Gift | $59.40 | 1 | 0.8% |
| Education | $30.04 | 3 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $1,025 | 47 | $0 (2024) |
| Novo Nordisk Inc | $864.34 | 30 | $0 (2024) |
| Corcept Therapeutics | $786.32 | 14 | $0 (2024) |
| Abbott Laboratories | $674.49 | 19 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $653.31 | 10 | $0 (2024) |
| Amgen Inc. | $496.03 | 6 | $0 (2024) |
| Dexcom, Inc. | $287.29 | 7 | $0 (2024) |
| Medtronic, Inc. | $234.08 | 6 | $0 (2023) |
| Horizon Therapeutics plc | $221.10 | 2 | $0 (2023) |
| MannKind Corporation | $219.72 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,012 | 20 | Amgen Inc. ($221.31) |
| 2023 | $1,727 | 35 | Corcept Therapeutics ($316.56) |
| 2022 | $1,414 | 30 | Lilly USA, LLC ($260.02) |
| 2021 | $881.19 | 17 | AstraZeneca Pharmaceuticals LP ($251.19) |
| 2020 | $736.54 | 22 | AstraZeneca Pharmaceuticals LP ($168.67) |
| 2019 | $567.20 | 11 | Corcept Therapeutics ($240.82) |
| 2018 | $464.47 | 13 | Amgen Inc. ($135.01) |
| 2017 | $736.51 | 47 | Novo Nordisk Inc ($294.91) |
All Payment Transactions
195 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $35.86 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $22.79 | General |
| 11/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Diabetes | ||||||
| 10/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Diabetes Care | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $115.92 | General |
| 08/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.93 | General |
| Category: Diabetes | ||||||
| 08/08/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.01 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $62.77 | General |
| Category: Growth Hormone | ||||||
| 06/21/2024 | Novo Nordisk Inc | Sogroya (Biological) | Food and Beverage | In-kind items and services | $38.46 | General |
| Category: Growth Hormone | ||||||
| 06/13/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $128.32 | General |
| Category: Endocrinology | ||||||
| 05/03/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Endocrinology | ||||||
| 04/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $105.26 | General |
| 04/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Diabetes | ||||||
| 03/20/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $28.91 | General |
| Category: IMMUNOLOGY | ||||||
| 03/14/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $115.08 | General |
| Category: Bone Health | ||||||
| 03/14/2024 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $106.23 | General |
| Category: Bone Health | ||||||
| 02/23/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: Diabetes | ||||||
| 02/22/2024 | Radius Health, Inc. | Tymlos (Drug) | Food and Beverage | In-kind items and services | $31.21 | General |
| Category: Endocrinology | ||||||
| 02/21/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $25.86 | General |
| Category: IMMUNOLOGY | ||||||
| 02/09/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $32.97 | General |
| Category: Endocrinology | ||||||
| 12/07/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Diabetes | ||||||
| 12/01/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: Diabetes | ||||||
| 11/24/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Diabetes Care | ||||||
| 11/09/2023 | Ascensia Diabetes Care Us Inc. | — | Food and Beverage | In-kind items and services | $137.49 | General |
| 11/09/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 472 | 793 | $139,959 | $78,929 |
| 2022 | 6 | 481 | 740 | $132,367 | $77,579 |
| 2021 | 6 | 464 | 755 | $132,721 | $78,702 |
| 2020 | 6 | 396 | 595 | $107,074 | $53,084 |
Total Patients
1,813
Total Services
2,883
Medicare Billing
$288,294
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 199 | 465 | $97,185 | $57,629 | 59.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 138 | $21,252 | $11,525 | 54.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 31 | 31 | $9,269 | $4,524 | 48.8% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 62 | 91 | $6,962 | $2,227 | 32.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 42 | 43 | $2,717 | $1,631 | 60.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 25 | $2,575 | $1,393 | 54.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 184 | 375 | $78,375 | $48,516 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 155 | 199 | $30,646 | $17,507 | 57.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 45 | 45 | $13,455 | $7,114 | 52.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 34 | $3,502 | $1,950 | 55.7% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 48 | 67 | $5,126 | $1,735 | 33.9% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 20 | 20 | $1,264 | $757.21 | 59.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 168 | 380 | $79,420 | $50,451 | 63.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 188 | $28,952 | $16,610 | 57.4% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 43 | 43 | $12,857 | $6,728 | 52.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2021 | 58 | 99 | $7,574 | $2,684 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 27 | 27 | $2,781 | $1,528 | 55.0% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 18 | 18 | $1,137 | $702.18 | 61.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 122 | 243 | $50,787 | $25,415 | 50.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 172 | 239 | $36,806 | $16,557 | 45.0% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 29 | 29 | $8,671 | $4,932 | 56.9% |
| 99354 | Prolonged office or other outpatient service first hour | Office | 2020 | 34 | 44 | $6,732 | $4,586 | 68.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 26 | $2,678 | $1,446 | 54.0% |
| 77081 | Bone density measurement using dedicated x-ray machine | Office | 2020 | 14 | 14 | $1,400 | $146.93 | 10.5% |
About Dr. John Sutton, DO
Dr. John Sutton, DO is a Endocrinology, Diabetes & Metabolism healthcare provider based in Carson City, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801812631.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Sutton, DO has received a total of $7,539 in payments from pharmaceutical and medical device companies, with $1,012 received in 2024. These payments were reported across 195 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($7,450).
As a Medicare-enrolled provider, Sutton has provided services to 1,813 Medicare beneficiaries, totaling 2,883 services with total Medicare billing of $288,294. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Carson City, NV
- Active Since 07/14/2006
- Last Updated 07/09/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801812631
Products in Payments
- Korlym (Drug) $786.32
- Ozempic (Drug) $354.21
- Victoza (Drug) $261.24
- EVENITY (Biological) $254.79
- JARDIANCE (Drug) $237.43
- Dexcom G6 Transmitter (Medical Supply) $236.43
- FREESTYLE LIBRE 3 (Device) $235.24
- TEPEZZA (Drug) $221.10
- AFREZZA (Drug) $219.72
- BAQSIMI (Drug) $208.44
- TRULICITY (Drug) $202.16
- FREESTYLE LIBRE 2 (Device) $201.11
- MINIMED 770G (Device) $184.58
- MYCAPSSA (Drug) $161.01
- FARXIGA (Drug) $154.91
- SYNTHROID (Drug) $153.30
- Prolia (Biological) $126.60
- RECORLEV (Drug) $123.92
- Tymlos (Biological) $122.07
- Repatha (Biological) $114.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.